FIMECS, Inc.

📍 藤沢市, Japan🗓 Founded 2018👥 15 employees💰 Last funded 2020
Pharmaceutical Manufacturing🌐 fimecs.com
Website LinkedIn
FIMECS, Inc. is developing a new class of drugs based on targeted protein degradation for the currently ‘undruggable’ targets in immuno-oncology and oncology areas. The company became able to discover drug candidates for inducing the degradation of disease-relevant targeted proteins by integrating proprietary E3 ligase binders and RaPPIDS™ platform. This drug discovery platform will help providing drugs to the patients all over the world through various internal and collaboration projects.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in FIMECS, Inc.?
FIMECS, Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did FIMECS, Inc. last raise funding?
The most recent investment in FIMECS, Inc. recorded on gritt.io was in 2020.
When was FIMECS, Inc. founded?
FIMECS, Inc. was founded in 2018.
What industry is FIMECS, Inc. in?
FIMECS, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is FIMECS, Inc. based?
FIMECS, Inc. is headquartered in 藤沢市, Japan.